Loading clinical trials...
Loading clinical trials...
An Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BAY 1163877 in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Conditions
Interventions
BAY1163877
Locations
2
Japan
Kashiwa, Chiba, Japan
Koto-ku, Tokyo, Japan
Start Date
December 15, 2015
Primary Completion Date
February 5, 2017
Completion Date
December 6, 2017
Last Updated
April 18, 2018
NCT07169851
NCT07213804
NCT00026884
NCT07159659
NCT06662786
NCT07191730
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions